Search

Alexander Gilman

Examiner (ID: 6523, Phone: (571)272-2004 , Office: P/2831 )

Most Active Art Unit
2833
Art Unit(s)
2833, 2831
Total Applications
3105
Issued Applications
2518
Pending Applications
101
Abandoned Applications
486

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17564423 [patent_doc_number] => 20220128572 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-28 [patent_title] => IMMUNOLOGICAL SIGNATURES AND PARAMETERS PREDICTING THERAPEUTIC RESPONSES TO ANTI-TNF THERAPY [patent_app_type] => utility [patent_app_number] => 17/567623 [patent_app_country] => US [patent_app_date] => 2022-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6906 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17567623 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/567623
IMMUNOLOGICAL SIGNATURES AND PARAMETERS PREDICTING THERAPEUTIC RESPONSES TO ANTI-TNF THERAPY Jan 2, 2022 Pending
Array ( [id] => 17685865 [patent_doc_number] => 20220193157 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-23 [patent_title] => LACTOBACILLUS COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF MICROBIAL INFECTION [patent_app_type] => utility [patent_app_number] => 17/557939 [patent_app_country] => US [patent_app_date] => 2021-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16533 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17557939 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/557939
LACTOBACILLUS COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF MICROBIAL INFECTION Dec 20, 2021 Pending
Array ( [id] => 18449512 [patent_doc_number] => 20230190788 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-22 [patent_title] => Method and process to make chitosan-doped strontium oxide nanocomposite for bactericidal applications [patent_app_type] => utility [patent_app_number] => 17/551882 [patent_app_country] => US [patent_app_date] => 2021-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3064 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 1 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17551882 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/551882
Method and process to make chitosan-doped strontium oxide nanocomposite for bactericidal applications Dec 14, 2021 Issued
Array ( [id] => 17685922 [patent_doc_number] => 20220193214 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-23 [patent_title] => Triple Vaccine for Diseases Caused by Salmonella typhimurium, Riemerella anatipestifer and Escherichia coli [patent_app_type] => utility [patent_app_number] => 17/532217 [patent_app_country] => US [patent_app_date] => 2021-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4371 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -2 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17532217 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/532217
Triple vaccine for diseases caused by Nov 21, 2021 Issued
Array ( [id] => 17561752 [patent_doc_number] => 20220125901 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-28 [patent_title] => TREATMENT OF CANCER USING RECALL ANTIGENS DELIVERED BY ATTENUATED BACTERIA [patent_app_type] => utility [patent_app_number] => 17/527488 [patent_app_country] => US [patent_app_date] => 2021-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5542 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17527488 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/527488
TREATMENT OF CANCER USING RECALL ANTIGENS DELIVERED BY ATTENUATED BACTERIA Nov 15, 2021 Abandoned
Array ( [id] => 17482150 [patent_doc_number] => 20220089654 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-24 [patent_title] => MUTANT TRANSPORTERS FOR BACTERIAL UPTAKE OF TEREPHTHALIC ACID [patent_app_type] => utility [patent_app_number] => 17/472936 [patent_app_country] => US [patent_app_date] => 2021-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18333 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17472936 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/472936
Mutant transporters for bacterial uptake of terephthalic acid Sep 12, 2021 Issued
Array ( [id] => 17593594 [patent_doc_number] => 20220143167 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-12 [patent_title] => SACCHARIDE-POLYPEPTIDE CONJUGATE COMPOSITIONS AND METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/347435 [patent_app_country] => US [patent_app_date] => 2021-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34141 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17347435 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/347435
SACCHARIDE-POLYPEPTIDE CONJUGATE COMPOSITIONS AND METHODS OF USE THEREOF Jun 13, 2021 Pending
Array ( [id] => 17760059 [patent_doc_number] => 20220233671 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-28 [patent_title] => SUBUNIT VACCINE OF CONTAGIOUS CAPRINE PLEUROPNEUMONIA AND PREPARATION METHOD AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/335573 [patent_app_country] => US [patent_app_date] => 2021-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6429 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17335573 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/335573
Subunit vaccine of contagious caprine pleuropneumonia and preparation method and use thereof May 31, 2021 Issued
Array ( [id] => 17242014 [patent_doc_number] => 20210361757 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-25 [patent_title] => STREPTOCOCCAL VACCINE FORMULATIONS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/327513 [patent_app_country] => US [patent_app_date] => 2021-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20199 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -93 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17327513 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/327513
STREPTOCOCCAL VACCINE FORMULATIONS AND USES THEREOF May 20, 2021 Pending
Array ( [id] => 17828431 [patent_doc_number] => 20220265735 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-25 [patent_title] => CANINE MICROBE PREPARATIONS FOR INCREASING OXYTOCIN [patent_app_type] => utility [patent_app_number] => 17/242635 [patent_app_country] => US [patent_app_date] => 2021-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22014 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17242635 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/242635
CANINE MICROBE PREPARATIONS FOR INCREASING OXYTOCIN Apr 27, 2021 Abandoned
Array ( [id] => 17170437 [patent_doc_number] => 20210324107 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-21 [patent_title] => USING C1 ESTERASE INHIBITOR TO TREAT VIRAL INFECTION-RELATED ACUTE RESPIRATORY DISTRESS [patent_app_type] => utility [patent_app_number] => 17/233901 [patent_app_country] => US [patent_app_date] => 2021-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17344 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -62 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17233901 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/233901
USING C1 ESTERASE INHIBITOR TO TREAT VIRAL INFECTION-RELATED ACUTE RESPIRATORY DISTRESS Apr 18, 2021 Pending
Array ( [id] => 17034238 [patent_doc_number] => 20210251196 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-19 [patent_title] => IMMUNE-ENHANCED AQUACULTURE [patent_app_type] => utility [patent_app_number] => 17/176513 [patent_app_country] => US [patent_app_date] => 2021-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4517 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17176513 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/176513
Immune-enhanced aquaculture Feb 15, 2021 Issued
Array ( [id] => 18271575 [patent_doc_number] => 20230092817 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-23 [patent_title] => RECOMBINANT THERAPEUTIC INTERVENTIONS FOR CANCER [patent_app_type] => utility [patent_app_number] => 17/797055 [patent_app_country] => US [patent_app_date] => 2021-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36286 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 125 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17797055 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/797055
RECOMBINANT THERAPEUTIC INTERVENTIONS FOR CANCER Feb 11, 2021 Pending
Array ( [id] => 18700080 [patent_doc_number] => 11786566 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-10-17 [patent_title] => None [patent_app_type] => utility [patent_app_number] => 17/141104 [patent_app_country] => US [patent_app_date] => 2021-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 30 [patent_no_of_words] => 5877 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17141104 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/141104
None Jan 3, 2021 Issued
Array ( [id] => 19076507 [patent_doc_number] => 11945857 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-04-02 [patent_title] => Methods and compositions related to soluble monoclonal variable lymphocyte receptors of defined antigen specificity [patent_app_type] => utility [patent_app_number] => 17/126396 [patent_app_country] => US [patent_app_date] => 2020-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 52 [patent_no_of_words] => 17970 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17126396 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/126396
Methods and compositions related to soluble monoclonal variable lymphocyte receptors of defined antigen specificity Dec 17, 2020 Issued
Array ( [id] => 17609820 [patent_doc_number] => 20220152099 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-19 [patent_title] => Method for the preparation of an anti-streptococcus serum for use in the treatment of Coronavirus-related diseases. [patent_app_type] => utility [patent_app_number] => 16/951906 [patent_app_country] => US [patent_app_date] => 2020-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1102 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16951906 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/951906
Method for the preparation of an anti-streptococcus serum for use in the treatment of Coronavirus-related diseases. Nov 17, 2020 Abandoned
Array ( [id] => 17154872 [patent_doc_number] => 20210315923 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-14 [patent_title] => LIPIDATED PSA COMPOSITIONS AND METHODS [patent_app_type] => utility [patent_app_number] => 17/088547 [patent_app_country] => US [patent_app_date] => 2020-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15438 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17088547 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/088547
LIPIDATED PSA COMPOSITIONS AND METHODS Nov 2, 2020 Pending
Array ( [id] => 18314132 [patent_doc_number] => 11628192 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-04-18 [patent_title] => None [patent_app_type] => utility [patent_app_number] => 17/082668 [patent_app_country] => US [patent_app_date] => 2020-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 8 [patent_no_of_words] => 3995 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17082668 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/082668
None Oct 27, 2020 Issued
Array ( [id] => 16807865 [patent_doc_number] => 20210130418 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-06 [patent_title] => CLAUDIN-TARGETING AGENTS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/073817 [patent_app_country] => US [patent_app_date] => 2020-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15034 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17073817 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/073817
Claudin-targeting agents and uses thereof Oct 18, 2020 Issued
Array ( [id] => 16620009 [patent_doc_number] => 20210038662 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-02-11 [patent_title] => Algal extract comprising sulphated and non-sulphated polyanionic polysaccharides and uses thereof [patent_app_type] => utility [patent_app_number] => 17/028768 [patent_app_country] => US [patent_app_date] => 2020-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9907 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17028768 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/028768
Algal extract comprising sulphated and non-sulphated polyanionic polysaccharides and uses thereof Sep 21, 2020 Issued
Menu